Albert Kim
Westmead Hospital, NSW, Australia
- This delegate is presenting an abstract at this event.
Albert is an Endocrinologist at Westmead Hospital, Sydney and a PhD candidate at the Garvan Institute of Medical Research. His research examines changes in osteoclast biology in the context of osteoporosis therapy to optimise long term management of osteoporosis.
His work in Endocrinology has been recognised in national and international meetings, including the ESA Clinical Weekend, ANZBMS Outstanding Abstracts Award and the ASBMR Young Investigator’s Award, and he is supported by the University Postgraduate Award from UNSW. He has also completed a Master of Medicine (Clinical Epidemiology) and committed to medical education as a Unit Coordinator (Advanced Endocrinology) with the University of Sydney.
Presentations this author is a contributor to:
A single centre experience of endocrine late effects following allogeneic bone marrow transplantation (#108)
2:00 PM
Madeleine Lim
ESA Clinical Orals and Lightning Talks
Clinicopathological features and outcomes of multifocal versus unifocal papillary thyroid carcinoma a retrospective cohort study (#113)
2:45 PM
Keshi Maheswaran
ESA Clinical Orals and Lightning Talks
Balancing efficacy and rebound risk: extending denosumab dosing intervals in low-risk patients (#388)
5:30 PM
Brenda Ta
Joint Poster Session
Development of a National Multidisciplinary Consensus Statement on Medication-Related Osteonecrosis of the Jaw (MRONJ) and Osteoporosis in Australia (#193)
2:00 PM
Christian Girgis
ESA and NZSE Clinical Orals and Lightning Talks